Di Nuzzo Private Wealth, Inc. Alnylam Pharmaceuticals, Inc. Transaction History
Di Nuzzo Private Wealth, Inc.
- $617 Million
- Q1 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 10 shares of ALNY stock, worth $2,632. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10
Previous 7
42.86%
Holding current value
$2,632
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ALNY
# of Institutions
688Shares Held
109MCall Options Held
839KPut Options Held
759K-
Capital World Investors Los Angeles, CA16.6MShares$4.37 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.35 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.51 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.83 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.15 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $32.4B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...